|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 1/18 | |
| C07K 16/06 |
| (11) | Patento numeris | 2710026 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12726891.0 |
| Europos patento paraiškos padavimo data | 2012-05-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2012/000189 |
| Data | 2012-05-14 |
| (87) | Numeris | WO 2012/156963 |
| Data | 2012-11-22 |
| (30) | Numeris | Data | Šalis |
| 21291111 | 2011-05-16 | IL | |
| 201161486386 P | 2011-05-16 | US | |
| 201161550581 P | 2011-10-24 | US |
| (72) |
MINTZ, Roni, IL
BELYAEV, Oleg, IL
NUR, Israel, IL
BAR, Liliana, IL
MEIDLER, Roberto, IL
|
| (73) |
Omrix Biopharmaceuticals Ltd.,
Bldg.14 Weizmann Science Park P.O. Box 619, Rehovot 76106,
IL
|
| (54) | IMMUNOGLOBULIN REDUCED IN THROMBOGENIC AGENTS AND PREPARATION THEREOF |
| IMMUNOGLOBULIN REDUCED IN THROMBOGENIC AGENTS AND PREPARATION THEREOF |